These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 12729406)

  • 41. Intracranial gliomas in neurofibromatosis type 1.
    Listernick R; Charrow J; Gutmann DH
    Am J Med Genet; 1999 Mar; 89(1):38-44. PubMed ID: 10469435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Neurofibromatosis type 1 in childhood].
    Kongshaug N; Meyer B; Kolmannskog S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(18):2653-7. PubMed ID: 10479978
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Growth hormone hypersecretion in a girl with neurofibromatosis type 1 and an optic nerve glioma: resolution following chemotherapy.
    Drake AJ; Lowis SP; Bouffet E; Crowne EC
    Horm Res; 2000; 53(6):305-8. PubMed ID: 11146372
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Growth tracks in pre-pubertal children.
    Hermanussen M; Grasedyck L; Kromeyer-Hauschild K; Prokopec M; Chrzastek-Spruch H
    Ann Hum Biol; 2002; 29(6):667-76. PubMed ID: 12573083
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Isolated premature menarche in two siblings with Neurofibromatosis type 1.
    Blackburn J; Didi M; Avula S; Senniappan S
    J Pediatr Endocrinol Metab; 2020 May; 33(6):813-816. PubMed ID: 32436861
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Endocrinologic disorders and optic pathway gliomas in children with neurofibromatosis type 1.
    Cnossen MH; Stam EN; Cooiman LC; Simonsz HJ; Stroink H; Oranje AP; Halley DJ; de Goede-Bolder A; Niermeijer MF; de Muinck Keizer-Schrama SM
    Pediatrics; 1997 Oct; 100(4):667-70. PubMed ID: 9310522
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Four generations in a family with neurofibromatosis 1: precocious puberty and optic nerve tumor (OPT).
    Gucev Z; Krstevska-Konstantinova M; Tasic V; Jancevska A; Kirovski I; Pop-Jordanova N
    Prilozi; 2010; 31(2):253-9. PubMed ID: 21258292
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neurofibromatosis type 1 (NF1) presenting with dichotomous pubertal presentation: A case series.
    Rai VR; Rathore H; Kumari M; Ibrahim MN; Riaz M; Parveen R
    J Pak Med Assoc; 2024 Sep; 74(9):1703-1706. PubMed ID: 39279083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.
    Listernick R; Ferner RE; Liu GT; Gutmann DH
    Ann Neurol; 2007 Mar; 61(3):189-98. PubMed ID: 17387725
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Height Growth Impairment in Children With Neurofibromatosis Type 1 Is Characterized by Decreased Pubertal Growth Velocity in Both Sexes.
    Zessis NR; Gao F; Vadlamudi G; Gutmann DH; Hollander AS
    J Child Neurol; 2018 Oct; 33(12):762-766. PubMed ID: 30009646
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Hypothalamic pubertas praecox (Part 2)].
    Mori K
    No Shinkei Geka; 1984 Oct; 12(11):1231-7. PubMed ID: 6440040
    [No Abstract]   [Full Text] [Related]  

  • 52. [Puberty and growth in children and adolescents with neuro fibromatosis type 1].
    Viana AC; Liberatore Junior R; Goloni Bertollo EM
    Rev Assoc Med Bras (1992); 2004; 50(2):163-6. PubMed ID: 15286864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.
    Guillamo JS; Créange A; Kalifa C; Grill J; Rodriguez D; Doz F; Barbarot S; Zerah M; Sanson M; Bastuji-Garin S; Wolkenstein P;
    Brain; 2003 Jan; 126(Pt 1):152-60. PubMed ID: 12477702
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gigantism due to growth hormone excess in a boy with optic glioma.
    Drimmie FM; MacLennan AC; Nicoll JA; Simpson E; McNeill E; Donaldson MD
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):535-8. PubMed ID: 11012581
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Elevated head circumference-to-height ratio is an early and frequent feature in children with neurofibromatosis type 1.
    Karvonen M; Saari A; Hannila ML; Lönnqvist T; Dunkel L; Sankilampi U
    Horm Res Paediatr; 2013; 79(2):97-102. PubMed ID: 23466600
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discordant puberty in monozygotic twin sisters with neurofibromatosis type 1 (NF1).
    Kelly TE; Sproul GT; Huerta MG; Rogol AD
    Clin Pediatr (Phila); 1998 May; 37(5):301-4. PubMed ID: 9597296
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Behavioral phenotype of neurofibromatosis, type 1.
    Kayl AE; Moore BD
    Ment Retard Dev Disabil Res Rev; 2000; 6(2):117-24. PubMed ID: 10899804
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endocrine implications of neurofibromatosis 1 in childhood.
    Bizzarri C; Bottaro G
    Horm Res Paediatr; 2015; 83(4):232-41. PubMed ID: 25659607
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Myopia in neurofibromatosis type 1.
    Garty BZ; Laor A; Danon YL
    Isr J Med Sci; 1996 May; 32(5):297-9. PubMed ID: 8641867
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Growth charts for young children with neurofibromatosis 1 (NF1).
    Szudek J; Birch P; Friedman JM
    Am J Med Genet; 2000 May; 92(3):224-8. PubMed ID: 10817659
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.